Overview
The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma
Status:
Enrolling by invitation
Enrolling by invitation
Trial end date:
2023-12-01
2023-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Spinal hemangioma is one of the most common benign vertebral tumours. Being mostly asymptomatic, it is still associated with a pain syndrome especially if encroaches into the neural canal. This study is organised to evaluate the efficacy and safety of β-blockers drugs in adults with spinal hemangioma.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Center for Vascular Pathology, MoscowTreatments:
Atenolol
Propranolol
Criteria
Inclusion Criteria:- vertebral hemangioma
Exclusion Criteria:
- symptomatic bradycardia
- AV block
- decompensated heart failure
- asthma